Relationship Between Macular Curvature and Common Causative Genes of Retinitis Pigmentosa in Japanese Patients.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 08 2020
Historique:
entrez: 5 8 2020
pubmed: 5 8 2020
medline: 2 1 2021
Statut: ppublish

Résumé

To determine the relationship between the macular curvature and the causative genes of retinitis pigmentosa (RP). We examined the medical records of the right eyes of 65 cases with RP (31 men and 34 women; average age, 47.6 years). There were 31 cases with the EYS variants, 11 cases with the USH2A variants, six cases with the RPGR variants, 13 cases with the RP1 variants, and four cases with the RP1L1 variants. The mean curvature of Bruch's membrane was calculated within 6 mm of the fovea as the mean macular curvature index (MMCI, 1/µm). We used multiple linear regression analysis to determine the independence of the causative genes contributing to the MMCIs after adjustments for age, sex, axial length, and width of the ellipsoid zone. The median MMCI was -31.2 × 10-5/µm for the RPGR eyes, -16.5 × 10-5/µm for the RP1L1 eyes, -13.0 × 10-5/µm for the RP1 eyes, -9.8 × 10-5/µm for the EYS eyes, and -9.0 × 10-5/µm for the USH2A eyes. Compared with the EYS gene as the reference gene, the RPGR gene was significantly related to the MMCI values after adjusting for the other parameters (P = 5.30 × 10-6). In contrast, the effects of the other genes, USH2A, RP1, and RP1L1, were not significantly different from that of the EYS gene (P = 0.26, P = 0.49, and P = 0.92, respectively). The RPGR gene had a stronger effect on the steep macular curvature than the other ciliopathy-related genes.

Identifiants

pubmed: 32749464
pii: 2770571
doi: 10.1167/iovs.61.10.6
pmc: PMC7441377
doi:

Substances chimiques

EYS protein, human 0
Extracellular Matrix Proteins 0
Eye Proteins 0
Microtubule-Associated Proteins 0
RP1 protein, human 0
RP1L1 protein, human 0
RPGR protein, human 0
USH2A protein, human 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Références

Prog Retin Eye Res. 2018 Jan;62:24-37
pubmed: 28962928
Hum Mol Genet. 2012 Oct 15;21(R1):R111-24
pubmed: 22843501
Hum Genet. 1990 Oct;85(6):635-42
pubmed: 2227956
Orphanet J Rare Dis. 2019 Aug 1;14(1):187
pubmed: 31370859
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3135-3141
pubmed: 31335951
N Engl J Med. 2011 Apr 21;364(16):1533-43
pubmed: 21506742
J Med Genet. 2019 Oct;56(10):662-670
pubmed: 31213501
Sci Rep. 2017 Apr 05;7:46098
pubmed: 28378834
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Br J Ophthalmol. 2015 Dec;99(12):1725-31
pubmed: 26294103
Eur J Ophthalmol. 2017 Jan 19;27(1):e16-e21
pubmed: 28009400
PLoS One. 2016 Nov 15;11(11):e0166397
pubmed: 27846257
Prog Retin Eye Res. 2018 Mar;63:107-131
pubmed: 29097191
Ophthalmic Genet. 2007 Sep;28(3):113-25
pubmed: 17896309
Adv Exp Med Biol. 2010;664:223-32
pubmed: 20238021
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7369-75
pubmed: 25324289
PLoS One. 2012;7(2):e31036
pubmed: 22363543
Ophthalmic Genet. 2018 Apr;39(2):255-262
pubmed: 29220607
Doc Ophthalmol. 2018 Aug;137(1):25-36
pubmed: 29987673
Ophthalmic Genet. 2019 Apr;40(2):170-176
pubmed: 31033374
Br J Ophthalmol. 2016 Aug;100(8):1022-7
pubmed: 26843488
Prog Retin Eye Res. 2018 Sep;66:157-186
pubmed: 29597005
Nat Med. 2020 Mar;26(3):354-359
pubmed: 32094925
Nat Commun. 2019 Jun 28;10(1):2884
pubmed: 31253780
Doc Ophthalmol. 2014 Jun;128(3):219-28
pubmed: 24752437
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5122-5128
pubmed: 28986597
Invest Ophthalmol Vis Sci. 2012 Feb 27;53(2):1033-40
pubmed: 22302105
Hum Genome Var. 2019 Aug 2;6:34
pubmed: 31645972
Ophthalmic Genet. 2019 Aug;40(4):365-368
pubmed: 31438752
Am J Ophthalmol. 2019 Feb;198:111-123
pubmed: 30312579
Genes (Basel). 2019 Sep 04;10(9):
pubmed: 31487940
Sci Rep. 2016 Dec 20;6:39179
pubmed: 27995965
Jpn J Ophthalmol. 2018 Jul;62(4):451-457
pubmed: 29785639
Retina. 2019 Jul;39(7):1299-1304
pubmed: 29708934

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH